Saleh A Naser1, George Ghobrial, Claudia Romero, John F Valentine. 1. Department of Molecular Biology and Microbiology and Biomolecular Science Center, Burnett College of Biomedical Sciences, University of Central Florida, Orlando, FL 32816, USA. nasers@mail.ucf.edu
Abstract
BACKGROUND: Crohn's disease, a form of inflammatory bowel disease, resembles some aspects of tuberculosis, leprosy, and paratuberculosis. The role of Mycobacterium avium subspecies paratuberculosis (MAP) in Crohn's disease is controversial. METHODS: We tested for MAP by PCR and culture in buffy coat preparations from 28 individuals with Crohn's disease, nine with ulcerative colitis, and 15 without inflammatory bowel disease. FINDINGS: MAP DNA in uncultured buffy coats was identified by PCR in 13 (46%) individuals with Crohn's disease, four (45%) with ulcerative colitis, and three (20%) without inflammatory bowel disease. Viable MAP was cultured from the blood of 14 (50%) patients with Crohn's disease, two (22%) with ulcerative colitis, and none of the individuals without inflammatory bowel disease. Current use of immunosuppressive medication did not correlate with a positive MAP culture. Sequencing of PCR products from MAP cultures confirmed the presence of the MAP-specific IS900 fragment. Among 11 MAP isolates assessed, we identified nine strains that were not identical. INTERPRETATION: We detected viable MAP in peripheral blood in a higher proportion of individuals with Crohn's disease than in controls. These data contribute to the evidence that MAP might be a cause of Crohn's disease.
BACKGROUND:Crohn's disease, a form of inflammatory bowel disease, resembles some aspects of tuberculosis, leprosy, and paratuberculosis. The role of Mycobacterium avium subspecies paratuberculosis (MAP) in Crohn's disease is controversial. METHODS: We tested for MAP by PCR and culture in buffy coat preparations from 28 individuals with Crohn's disease, nine with ulcerative colitis, and 15 without inflammatory bowel disease. FINDINGS:MAP DNA in uncultured buffy coats was identified by PCR in 13 (46%) individuals with Crohn's disease, four (45%) with ulcerative colitis, and three (20%) without inflammatory bowel disease. Viable MAP was cultured from the blood of 14 (50%) patients with Crohn's disease, two (22%) with ulcerative colitis, and none of the individuals without inflammatory bowel disease. Current use of immunosuppressive medication did not correlate with a positive MAP culture. Sequencing of PCR products from MAP cultures confirmed the presence of the MAP-specific IS900 fragment. Among 11 MAP isolates assessed, we identified nine strains that were not identical. INTERPRETATION: We detected viable MAP in peripheral blood in a higher proportion of individuals with Crohn's disease than in controls. These data contribute to the evidence that MAP might be a cause of Crohn's disease.
Authors: Adrienne L McNees; Diane Markesich; Najah R Zayyani; David Y Graham Journal: Expert Rev Gastroenterol Hepatol Date: 2015-10-16 Impact factor: 3.869
Authors: R W Pickup; G Rhodes; T J Bull; S Arnott; K Sidi-Boumedine; M Hurley; J Hermon-Taylor Journal: Appl Environ Microbiol Date: 2006-06 Impact factor: 4.792
Authors: Tomás López-Pedemonte; Iker Sevilla; Joseba M Garrido; Gorka Aduriz; Buenaventura Guamis; Ramón A Juste; Artur X Roig-Sagués Journal: Appl Environ Microbiol Date: 2006-06 Impact factor: 4.792
Authors: Josef Wagner; Narelle A Skinner; Anthony G Catto-Smith; Donald J S Cameron; Wojtek P Michalski; Kumar Visvanathan; Carl D Kirkwood Journal: Med Microbiol Immunol Date: 2013-03-02 Impact factor: 3.402